Miranda H. Meeuwsen

TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

Lorenz Jahn, Pleun Hombrink, Renate S. Hagedoorn et al. · Blood · 2017 · 55 citations · Full text

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure

Tassilo L A Wachsmann, Anne K. Wouters, Dennis F.G. Remst et al. · OncoImmunology · 2022 · 47 citations · Full text

Cell Therapy, T-regulatory Cell, Immunology +17

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S

Tom J. Harryvan, Marten Visser, Linda de Bruin et al. · Journal for ImmunoTherapy of Cancer · 2022 · 38 citations · Full text

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion

Laura T. Morton, Tassilo L A Wachsmann, Miranda H. Meeuwsen et al. · Journal for ImmunoTherapy of Cancer · 2022 · 27 citations · Full text

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

Marije A.J. de Rooij, Dennis F.G. Remst, Dirk M. van der Steen et al. · Molecular Therapy — Oncolytics · 2022 · 19 citations · Full text